• SENSEX 74,752.92
    223.84 (+0.30%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Meesho
    230.80 125.70(%)
  • Allied Blenders
    667.75 719.95(%)
  • Swiggy
    279.80 235.85(%)
  • Kanohar Elect.
    938.00 905.50(%)
  • Ola Electric
    42.32 59.20(%)
  • Tour. Fin. Corp.
    143.00 148.00(%)
  • Glass Wall Syst.
    296.05 185.05(%)
  • PC Jeweller
    14.87 14.45(%)
  • Kotak Mah. Bank
    416.70 452.98(%)
  • Transrail Light
    471.00 401.00(%)
  • HDFC Bank
    741.45 1,020.35(%)
  • Cupid
    264.00 298.95(%)
  • Solar Industries
    20,362.20 22,630.05(%)
  • Wockhardt
    2,359.60 2,420.00(%)
  • Ather Energy
    1,484.00 535.00(%)
  • ESDS Software
    1,788.65 1,824.80(%)
  • Welspun Corp
    2,835.00 2,828.90(%)
  • AAVAS Financiers
    1,339.10 1,774.95(%)
  • Indo-MIM
    1,293.25 1,248.00(%)
  • Anzen IYEP Trust
    129.00 114.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sakar Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 66415.0
  • ISIN : INE732S01012
1,188.40 30 (2.59%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    1,145.00

  • Today’s High

    1,196.90

  • Open

    1,168.00

  • Perv Close

    1,158.45

  • 52W Low

    333.50

  • 52W High

    1,227.00

Key Indicators

  • P/E(TTM)

    73.27

  • Mar.Cap (₹Cr.)

    2,644.18

  • Div & Yield %

    0.00

  • Book Value(₹)

    145.86

  • Debt-Equity Ratio

    2.59

  • AGM Date

    22-Sep-2026

  • EPS

    16.22

  • P/E Ratio

    73.27

Financials Ratios

  • Debt-Equity Ratio

    0.46

  • Mar.Cap (₹Cr.)

    2,644.18

  • RONW (%)

    5.36

  • ROCE (%)

    7.36

Score Board

  • Equity (₹ in Cr.)

    22.25

  • BV (₹)

    145.90

  • Sales( ₹ in Cr.)

    251.74

  • NP (in Cr.)

    30.48

  • NP Var(%)

    72.0

  • Div%

    0.0

  • CPS (₹)

    24.30

  • EPS (₹)

    13.70

  • Traded Value (₹ in Lakhs)

    2,644.18

  • 52 Week High

    1,227.00

  • 52 Week Low

    333.50

  • Price BSE

    0.0

  • Price NSE

    1,188.00

  • Market Capital( in Cr.)

    2,644.18

  • P/C Ratio

    48.90

  • P/E Ratio

    86.70

  • Price Vs.BV

    13.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 251.74 177.58 153.35 133.36 128.23 94.74
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 251.74 177.58 153.35 133.36 128.23 94.74
Other Income 2.29 1.31 3.18 4.67 2.17 1.18
Stock Adjustments 9.41 13.20 1.38 0.36 -0.93 0.91
Total Income 263.44 192.09 157.91 138.39 129.47 96.83
EXPENDITURE :            
Raw Materials 132.75 95.47 85.05 74.00 73.69 52.20
Power and Fuel Cost 6.38 5.15 4.25 2.90 3.01 2.26
Employee Cost 34.40 30.15 18.82 15.81 14.26 12.74
Other Manufacturing Expenses 2.22 0.36 0.74 0.69 0.95 0.90
Selling and Administration Expenses 15.58 8.91 6.92 6.85 5.70 4.11
Miscellaneous Expenses 0.94 1.12 0.57 0.34 0.28 0.84
Employee Benefit Expenses 34.40 30.15 18.82 15.81 14.26 12.74
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 192.26 141.16 116.36 100.58 97.89 73.04
Operating Profit 71.18 50.95 41.54 37.81 31.58 23.78
Interest 7.86 8.54 7.59 5.95 2.90 2.48
Gross Profit 63.32 42.41 33.95 31.86 28.68 21.30
Depreciation 23.56 20.88 18.05 14.99 9.67 8.06
Profit Before Tax 39.76 21.53 15.90 16.87 19.01 13.24
Current Tax 6.23 0.00 0.00 0.00 3.41 3.18
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.04 4.03 4.23 4.12 0.35 -0.63
Reported Net Profit 30.48 17.50 11.67 12.76 15.24 10.69
Extraordinary Items 0.00 -0.25 0.17 0.07 0.03 -0.11
Adjusted Net Profit 30.48 17.75 11.50 12.69 15.21 10.80
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -0.75
P & L Balance brought forward 98.12 80.62 68.95 56.19 40.95 31.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 128.61 98.12 80.62 68.95 56.19 40.95
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 13.70 7.97 5.37 6.70 8.90 6.85
Earnings Per Share(Adj)-Unit Curr 13.70 7.97 5.37 6.70 8.90 6.85
Book Value 145.86 128.78 118.44 91.09 74.50 63.04
Book Value(Adj)-Unit Curr 145.86 128.78 118.44 91.09 74.50 63.04

Shareholding Pattern

  • Promoter Group

    52.52%

  • Public Share Holding

    47.48%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,685,043 52.52 11,685,043 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,685,043 52.52 11,685,043 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,700,018 12.13 2,700,018 10
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,529,958 11.37 2,529,958 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,229,976 23.51 5,229,976 17
2] Non Institution
Bodies Corporate 468,885 2.11 468,885 101
Clearing Members 9,489 0.04 9,489 9
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 203,587 0.92 203,587 327
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 172,562 0.78 172,562 305
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 866,723 3.90 866,723 19
Individuals holding nominal share capital up to Rs. 1 lakh 3,573,971 16.06 3,573,971 13,931
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2 0.00 2 1
Sub Total 5,334,891 23.98 5,334,891 14,713
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 22,249,910 100.00 22,249,910 14,734

Company Background

Sakar Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Sakar Healthcare Ltd
  • BSE Code : 66415.0
  • ISIN : INE732S01012

  • Incorporation Year

    2004

  • Registered Office

    10/13 Nr MN Desai Petrol Pump
    Sarkhej Bavla Highway, Changodar,
    Gujarat-382213

  • Telephone

    91-2717-250477

  • FAX

    91-2717-251621

  • Chairman

    Sanjay S Shah.

  • Managing Director

    Sanjay S Shah.

  • Company Secretary

    Bharat Soni

  • Auditor

    J S Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Sakar Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sakar Healthcare 1,188.40 254.02 251.74 73.27 12.33
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77